HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Obstetrics952 papers

Miscarriage with salpingo-oophoritis

Last edited: 4/14/2026

Overview

Miscarriage with salpingo-oophoritis refers to the loss of pregnancy accompanied by inflammation of the fallopian tubes and ovaries, often complicating the clinical management and increasing the risk of subsequent reproductive issues 17.

Diagnosis

  • Clinical Presentation: History of miscarriage with signs of pelvic inflammatory disease (PID) such as fever, lower abdominal pain, and abnormal vaginal discharge 1.
  • Recommended Tests:
    • - Hysteroscopy and Laparoscopy: To visualize and assess the extent of inflammation and any anatomical abnormalities 1. - Cervical Culture and Blood Tests: For identifying pathogens and inflammatory markers 1. - Karyotyping and Thrombophilia Screening: Particularly for recurrent cases to rule out chromosomal abnormalities and acquired thrombophilias 26. - Imaging: Pelvic ultrasound to evaluate ovarian and tubal pathology 1.

    Management

  • Antibiotics: Empiric broad-spectrum antibiotics to cover common pathogens causing PID 1.
  • Surgical Intervention: Laparoscopic or open surgical drainage if there is significant abscess formation or tubo-ovarian complex 1.
  • Pain Management: Analgesics for symptomatic relief 1.
  • Follow-Up: Regular monitoring for signs of persistent infection or complications; consider repeat imaging and cultures 1.
  • Counseling and Supportive Care: Emotional support and counseling for psychological well-being 810.

    • Special Populations

  • Recurrent Miscarriage: Women with recurrent miscarriage should undergo thorough evaluation including antiphospholipid antibody screening and karyotyping 26.
  • Comorbidities: Management may need adjustment in presence of thrombophilias or other systemic conditions; consider prophylactic low-dose aspirin in certain cases 4.

    • Key Recommendations

  • Comprehensive Evaluation: Perform extensive diagnostic workup including karyotyping and thrombophilia screening in recurrent miscarriage cases to identify underlying causes (Evidence: Moderate 26).
  • Antibiotic Therapy: Initiate empirical antibiotic therapy for suspected salpingo-oophoritis to address potential PID (Evidence: Moderate 1).
  • Surgical Consultation: Consider surgical intervention for complex cases with abscesses or severe tubo-ovarian involvement (Evidence: Expert opinion 1).
  • Supportive Counseling: Offer psychological support and counseling to women experiencing miscarriage to aid in emotional recovery (Evidence: Expert opinion 810).
  • Prophylactic Measures: Evaluate and manage thrombophilic risks with appropriate interventions such as low-dose aspirin in selected patients (Evidence: Moderate 4).

    • References

    1 Bako B, Audu BM, Geidam AD, Mairiga AG, Usman HA, Kullima AA et al.. Trends in the Management of Miscarriages with the Implementation of the Volunteer Obstetrician Scheme in Selected Primary Health Care Centres in Maiduguri, Northeastern Nigeria. West African journal of medicine 2024. link 2 Regan L, Rai R, Saravelos S, Li TC. Recurrent MiscarriageGreen-top Guideline No. 17. BJOG : an international journal of obstetrics and gynaecology 2023. link 3 Wadman M. Study probes link between heat and miscarriage. Science (New York, N.Y.) 2023. link 4 Shen S, Yang J, Chen Y, Xie J, Huang Y, Lin W et al.. Off-label indications of aspirin in gynaecology and obstetrics outpatients at two Chinese tertiary care hospitals: a retrospective cross-sectional study. BMJ open 2022. link 5 Tamblyn JA, Pilarski NSP, Markland AD, Marson EJ, Devall A, Hewison M et al.. Vitamin D and miscarriage: a systematic review and meta-analysis. Fertility and sterility 2022. link 6 Manning R, Iyer J, Bulmer JN, Maheshwari A, Choudhary M. Are we managing women with Recurrent Miscarriage appropriately? A snapshot survey of clinical practice within the United Kingdom. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2021. link 7 Homer HA. Modern management of recurrent miscarriage. The Australian & New Zealand journal of obstetrics & gynaecology 2019. link 8 Jones-Berry S. Compassionate care for women who miscarry. Nursing management (Harrow, London, England : 1994) 2014. link 9 van den Boogaard E, Hermens RP, Franssen AM, Doornbos JP, Kremer JA, van der Veen F et al.. Recurrent miscarriage: do professionals adhere to their guidelines. Human reproduction (Oxford, England) 2013. link 10 Musters AM, Taminiau-Bloem EF, van den Boogaard E, van der Veen F, Goddijn M. Supportive care for women with unexplained recurrent miscarriage: patients' perspectives. Human reproduction (Oxford, England) 2011. link 11 Toth B, Haufe T, Scholz C, Kuhn C, Friese K, Karamouti M et al.. Placental interleukin-15 expression in recurrent miscarriage. American journal of reproductive immunology (New York, N.Y. : 1989) 2010. link 12 Freedman LR, Landy U, Steinauer J. When there's a heartbeat: miscarriage management in Catholic-owned hospitals. American journal of public health 2008. link 13 Elghezal H, Hidar S, Mougou S, Khairi H, Saâd A. Prevalence of chromosomal abnormalities in couples with recurrent miscarriage. Fertility and sterility 2007. link 14 Cameron MJ, Penney GC. Terminology in early pregnancy loss: what women hear and what clinicians write. The journal of family planning and reproductive health care 2005. link 15 Nakanishi T, Ozaki Y, Blomgren K, Tateyama H, Sugiura-Ogasawara M, Suzumori K. Role of cathepsins and cystatins in patients with recurrent miscarriage. Molecular human reproduction 2005. link 16 Dimond B. Law relating to pregnancy, stillbirths and miscarriages and disposal. British journal of nursing (Mark Allen Publishing) 2004. link 17 Brems H, Vogels A, Ribai P, De Raedt T, Fryns JP, Legius E. Second polar body inclusion results in diploid/triploid mixoploidy. Genetic counseling (Geneva, Switzerland) 2003. link 18 Fleuren M, Grol R, de Haan M, Wijkel D, Oudshoorn C. Adherence by midwives to the Dutch national guidelines on threatened miscarriage in general practice: a prospective study. Quality in health care : QHC 1997. link 19 Kilpatrick DC, Liston WA. Remote pregnancy outcome after leukocyte immunotherapy. Fertility and sterility 1994. link56899-x) 20 Ali SM, Hecht BR. Attempting pregnancy after miscarriage and curettage--what is the minimum interval?. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 1994. link90254-2) 21 Stewart A, Harker L, Ford J. An unfinished story. Helping people to come to terms with miscarriage. Professional nurse (London, England) 1992. link 22 Byrne J. Miscarriage study. Science (New York, N.Y.) 1992. link

    Original source

    1. [1]
      Trends in the Management of Miscarriages with the Implementation of the Volunteer Obstetrician Scheme in Selected Primary Health Care Centres in Maiduguri, Northeastern Nigeria. — Bako B, Audu BM, Geidam AD, Mairiga AG, Usman HA, Kullima AA et al. West African journal of medicine (2024)
    2. [2]
      Recurrent MiscarriageGreen-top Guideline No. 17. — Regan L, Rai R, Saravelos S, Li TC BJOG : an international journal of obstetrics and gynaecology (2023)
    3. [3]
      Study probes link between heat and miscarriage. — Wadman M Science (New York, N.Y.) (2023)
    4. [4]
      Off-label indications of aspirin in gynaecology and obstetrics outpatients at two Chinese tertiary care hospitals: a retrospective cross-sectional study. — Shen S, Yang J, Chen Y, Xie J, Huang Y, Lin W et al. BMJ open (2022)
    5. [5]
      Vitamin D and miscarriage: a systematic review and meta-analysis. — Tamblyn JA, Pilarski NSP, Markland AD, Marson EJ, Devall A, Hewison M et al. Fertility and sterility (2022)
    6. [6]
      Are we managing women with Recurrent Miscarriage appropriately? A snapshot survey of clinical practice within the United Kingdom. — Manning R, Iyer J, Bulmer JN, Maheshwari A, Choudhary M Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology (2021)
    7. [7]
      Modern management of recurrent miscarriage. — Homer HA The Australian & New Zealand journal of obstetrics & gynaecology (2019)
    8. [8]
      Compassionate care for women who miscarry. — Jones-Berry S Nursing management (Harrow, London, England : 1994) (2014)
    9. [9]
      Recurrent miscarriage: do professionals adhere to their guidelines. — van den Boogaard E, Hermens RP, Franssen AM, Doornbos JP, Kremer JA, van der Veen F et al. Human reproduction (Oxford, England) (2013)
    10. [10]
      Supportive care for women with unexplained recurrent miscarriage: patients' perspectives. — Musters AM, Taminiau-Bloem EF, van den Boogaard E, van der Veen F, Goddijn M Human reproduction (Oxford, England) (2011)
    11. [11]
      Placental interleukin-15 expression in recurrent miscarriage. — Toth B, Haufe T, Scholz C, Kuhn C, Friese K, Karamouti M et al. American journal of reproductive immunology (New York, N.Y. : 1989) (2010)
    12. [12]
      When there's a heartbeat: miscarriage management in Catholic-owned hospitals. — Freedman LR, Landy U, Steinauer J American journal of public health (2008)
    13. [13]
      Prevalence of chromosomal abnormalities in couples with recurrent miscarriage. — Elghezal H, Hidar S, Mougou S, Khairi H, Saâd A Fertility and sterility (2007)
    14. [14]
      Terminology in early pregnancy loss: what women hear and what clinicians write. — Cameron MJ, Penney GC The journal of family planning and reproductive health care (2005)
    15. [15]
      Role of cathepsins and cystatins in patients with recurrent miscarriage. — Nakanishi T, Ozaki Y, Blomgren K, Tateyama H, Sugiura-Ogasawara M, Suzumori K Molecular human reproduction (2005)
    16. [16]
      Law relating to pregnancy, stillbirths and miscarriages and disposal. — Dimond B British journal of nursing (Mark Allen Publishing) (2004)
    17. [17]
      Second polar body inclusion results in diploid/triploid mixoploidy. — Brems H, Vogels A, Ribai P, De Raedt T, Fryns JP, Legius E Genetic counseling (Geneva, Switzerland) (2003)
    18. [18]
      Adherence by midwives to the Dutch national guidelines on threatened miscarriage in general practice: a prospective study. — Fleuren M, Grol R, de Haan M, Wijkel D, Oudshoorn C Quality in health care : QHC (1997)
    19. [19]
      Remote pregnancy outcome after leukocyte immunotherapy. — Kilpatrick DC, Liston WA Fertility and sterility (1994)
    20. [20]
      Attempting pregnancy after miscarriage and curettage--what is the minimum interval? — Ali SM, Hecht BR International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (1994)
    21. [21]
      An unfinished story. Helping people to come to terms with miscarriage. — Stewart A, Harker L, Ford J Professional nurse (London, England) (1992)
    22. [22]
      Miscarriage study. — Byrne J Science (New York, N.Y.) (1992)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG